Qvr LLC Amgen Inc Call Options Transaction History

Qvr LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $1.19 Million - $1.34 Million	-5,300 Reduced 56.38%	4,100 $925,000
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $2.33 Million - $2.59 Million	-10,100 Reduced 51.79%	9,400 $2.29 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $4.28 Million - $4.73 Million	19,500 New	19,500 $4.72 Million
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $1.25 Million - $1.43 Million	-6,300 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $636,810 - $746,100	3,000 Added 90.91%	6,300 $1.34 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $537,234 - $596,022	2,300 Added 230.0%	3,300 $804,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $177,528 - $206,880	800 Added 400.0%	1,000 $250,000
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $43,276 - $51,534	200 New	200 $46,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.